Top compounds associated with response to RRAGA


Feature Type Standardized
Nominal ANOVA
mRNA CIL70 CTRPv2 pan-cancer AAC 0.024 0.7
mRNA PIK-93 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Vandetanib FIMM pan-cancer AAC 0.085 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Erlotinib gCSI pan-cancer AAC -0.025 0.7
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA Bicalutamide FIMM pan-cancer AAC 0.079 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.025 0.7
mRNA erismodegib CTRPv2 pan-cancer AAC -0.017 0.7
Download CSV